Skip to content
Screener

Prestige Consumer Healthcare PBH Q1 2027 earnings

Reported August 6, 2026 · Before market open

Revenue$265.7MBeat by $12.7M
EPS$0.98Beat by $0.09
Revenue estimate$253.0M
EPS estimate$0.89
“First quarter performance exceeded our sales and earnings expectations, helped by strength across multiple categories that more than offset a challenging consumer backdrop and Clear Eyes® variability. We were also pleased to close the Breathe Right® acquisition late in the quarter, which added an incremental $6 million in revenue and is positioned well for long-term growth. These strong business results generated robust record adjusted free cash flow in the first quarter, leaving us well positioned to rapidly deleverage in the quarters ahead.”
Ron Lombardi

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$329.1M
EPS estimate$1.06

Financials

Q1 2027

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$2.21B-29.3%
Enterprise value$4.19B+3.7%
P/E12.9×-1.8×
P/S2×-0.8×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Segments

By product

See full
Gastrointestinal$62.2M+7.6%
Women's Health$52.5M-3.7%
Dermatologicals$33.2M+10.2%
Eye & Ear Care$33.0M+2.1%
Pain Relief$26.8M—

By segment

See full
North American OTC Healthcare$226.2M+6.4%
International OTC Healthcare$39.5M+6.9%

FAQ

When did Prestige Consumer Healthcare report Q1 2027 earnings?
Prestige Consumer Healthcare (PBH) reported Q1 2027 earnings on August 6, 2026 before market open.
What were Prestige Consumer Healthcare's Q1 2027 revenue and EPS?
Prestige Consumer Healthcare reported revenue of $265.7M and eps of $0.98 for Q1 2027.
Did Prestige Consumer Healthcare beat estimates in Q1 2027?
Revenue beat the consensus estimate of $253.0M by $12.7M. EPS beat the consensus estimate of $0.89 by $0.09.
How did Prestige Consumer Healthcare's Q1 2027 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.5% from $249.5M a year earlier and eps grew 3.2% from $0.95.
Where can I find Prestige Consumer Healthcare's Q1 2027 SEC filings?
You can read the 8-K earnings release (0001295947-26-000040) and the 10-Q periodic report (0001295947-26-000042) directly on SEC EDGAR. The filing index links above go to sec.gov.